• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    2/12/24 1:07:28 PM ET
    $AEY
    $ANTX
    $APLD
    $ARM
    Office Equipment/Supplies/Services
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEY alert in real time by email

    Shares of Big Lots, Inc. (NYSE:BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results.

    Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1.

    Big Lots shares dipped 31.3% to $3.6850 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Millennium Group International Holdings Limited (NASDAQ:MGIH) surged 250% to $3.61 after YC 1926 (BVI) Limited reported an 88.89% stake in the company in a 13G filing on Friday.
    • Beamr Imaging Ltd. (NASDAQ:BMR) shares climbed 241.5% to $7.20 after the company announced it will present its joint research relating to automated video modernization with NVIDIA at the ACM Mile-High-Video 2024 conference.
    • DIH Holdings US, Inc. (NASDAQ:DHAI) shares climbed 65.2% to $2.1306. DIH Holding US secured $1.5 million in private placement financing from OrbiMed.
    • ContextLogic Inc. (NASDAQ:WISH) gained 40.2% to $6.31 after the company announced an agreement to sell substantially all of its operating assets and liabilities to Qoo10 for approximately $173 million in cash.
    • SuperCom Ltd. (NASDAQ:SPCB) shares jumped 40% to $0.2570. SuperCom recently disclosed that it has secured a new contract with an established California services provider in the judicial sector.
    • Intuitive Machines, Inc. (NASDAQ:LUNR) shares gained 33.3% to $6.65 after jumping around 32% on Friday.
    • D-Wave Quantum Inc. (NYSE:QBTS) gained 31% to $1.4295.
    • Renalytix Plc (NASDAQ:RNLX) surged 27% to $0.4842.
    • Genasys Inc. (NASDAQ:GNSS) gained 27% to $1.98. Genasys bagged critical infrastructure project to engineer, procure and build emergency warning system for 37 dams across the island of Puerto Rico.
    • Root, Inc. (NASDAQ:ROOT) rose 22.6% to $9.30.
    • Syra Health Corp. (NASDAQ:SYRA) surged 21.7% to $3.5550. Syra Health announced a healthcare workforce contract with Fairfax County, Virginia.
    • 2U, Inc. (NASDAQ:TWOU) gained 19% to $0.9449.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) gained 18.4% to $5.79. T2 Biosystems received the FDA 510(k) clearance for expanded T2Bacteria Panel.
    • Amtech Systems, Inc. (NASDAQ:ASYS) rose 14.8% to $3.95 after the company reported upbeat results for its first quarter on Friday.
    • Viavi Solutions Inc. (NASDAQ:VIAV) gained 14.1% to $10.16. Stifel analyst Ruben Roy upgraded Viavi Solutions from Hold to Buy and raised the price target from $10 to $13.
    • SeaStar Medical Holding Corporation (NASDAQ:ICU) shares gained 14% to $0.9801. SeaStar Medical was recently granted Canadian patent with broad claims covering cytopheretic device technology.
    • The E.W. Scripps Company (NASDAQ:SSP) gained 14% to $6.69.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) rose 13.7% to $16.50. RBC Capital recently upgraded the stock from Sector Perform to Outperform and raised its price target from $9 to $21.
    • Cipher Mining Inc. (NASDAQ:CIFR) gained 13.2% to $3.7942.
    • V.F. Corporation (NYSE:VFC) jumped 10.8% to $16.95. Reuters reported Engaged Capital gained support of VF Corp heirs in push for changes.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) shares gained 9.6% to $0.7999 after rising around 6% on Friday.
    • B. Riley Financial, Inc. (NASDAQ:RILY) rose 9.6% to $20.33.
    • Arm Holdings plc (NASDAQ:ARM) gained 7.8% to $124.19.

    Losers

    • AN2 Therapeutics, Inc. (NASDAQ:ANTX) shares dropped 73% to $5.35 after the company announced it will voluntarily pause enrollment in the Phase 3 part of the Phase 2/3 pivotal clinical trial evaluating epetraborole in treatment-refractory MAC lung disease.
    • AirTouch Communications, Inc. (NYSE:ATCH) fell 49.6% to $ 5.17.
    • TOP Financial Group Limited (NASDAQ:TOP) fell 40% to $3.21 after the company announced a $5 million registered direct offering of 2,000,000 shares and warrants at $2.50 per share and accompanying warrant.
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) fell 36.3% to $2.0199.
    • ADDvantage Technologies Group, Inc. (NASDAQ:AEY) dipped 34.8% to $0.3910.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 34.5% to $0.0520. WiSA Technologies priced 153,840,000 unit offering for gross proceeds of $10 million.
    • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) fell 33.3% to $0.3253.
    • Hitek Global Inc. (NASDAQ:HKIT) shares fell 29.6% to $1.90 after dipping over 25% on Friday.
    • Lakeshore Acquisition II Corp. (NASDAQ:LBBB) fell 29.2% to $7.90.
    • Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) fell 25.2% to $4.74.
    • NanoString Technologies, Inc. (NASDAQ:NSTG) dipped 23% to $0.1771.
    • Safety Shot, Inc. (NASDAQ:SHOT) fell 20.5% to $3.0250.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) shares declined 18% to $17.48 after dipping over 25% on Friday. The company recently said it is planning to join the Communications Industry Association.
    • Invivyd, Inc. (NASDAQ:IVVD) fell 16.1% to $4.18.
    • Chenghe Acquisition Co. (NASDAQ:CHEA) shares fell 15.6% to $5.52. According to an SEC filing, Chenghe shareholders voted to approve the business combination with Taiwan Color Optics, Inc. dated July 21, 2023.
    • Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares fell 14.1% to $5.79. Intelligent Bio Solutions shares jumped around 135% on Friday after the company reported second-quarter financial results.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) fell 13.6% to $ 6.70 after the company reported top-line data from the Phase 2 dose exploration study from the 25 mg and 50 mg cohorts of nomlabofusp in patients with Friedreich's ataxia.
    • SunCar Technology Group Inc. (NASDAQ:SDA) fell 11% to $6.45.
    • Verastem, Inc. (NASDAQ:VSTM) fell 10.4% to $11.84.
    • Janux Therapeutics, Inc. (NASDAQ:JANX) fell 9.6% to $8.51.
    • monday.com Ltd. (NASDAQ:MNDY) fell 8.8% to $215.21 after the company reported quarterly results and issued FY24 guidance.
    • Manchester United plc (NYSE:MANU) fell 8.4% to $19.35.
    • Applied Digital Corporation (NASDAQ:APLD) shares declined 5% to $5.01 after gaining 5% on Friday. Applied Digital, last month, reported worse-than-expected second-quarter financial results.

     

    Now Read This: Jim Cramer Says This Construction Giant Is 'So Good' And 'Goes Higher'

    Get the next $AEY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEY
    $ANTX
    $APLD
    $ARM

    CompanyDatePrice TargetRatingAnalyst
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    monday.com Ltd.
    $MNDY
    2/23/2026$80.00Buy → Hold
    Jefferies
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    monday.com Ltd.
    $MNDY
    2/10/2026$90.00Outperform → Neutral
    Robert W. Baird
    Cipher Digital Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    Arm Holdings plc
    $ARM
    2/5/2026Neutral → Buy
    New Street
    Verastem Inc.
    $VSTM
    2/4/2026$18.00Buy
    H.C. Wainwright
    More analyst ratings

    $AEY
    $ANTX
    $APLD
    $ARM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Granado Corina S. bought $266,725 worth of Class A Common Shares (60,266 units at $4.43), increasing direct ownership by 9% to 720,517 units (SEC Form 4)

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/6/26 5:00:35 PM ET
    $SSP
    Broadcasting
    Industrials

    Large owner Evans Peggy Scripps bought $19,042 worth of Class A Common Shares (4,423 units at $4.31) (SEC Form 4)

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/6/26 5:00:36 PM ET
    $SSP
    Broadcasting
    Industrials

    Large owner Scripps Eaton M bought $253,940 worth of Class A Common Shares (58,983 units at $4.31), increasing direct ownership by 5% to 1,347,168 units (SEC Form 4)

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/6/26 5:00:26 PM ET
    $SSP
    Broadcasting
    Industrials

    $AEY
    $ANTX
    $APLD
    $ARM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by E.W. Scripps Company

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/10/26 5:00:14 PM ET
    $SSP
    Broadcasting
    Industrials

    SEC Form 4 filed by E.W. Scripps Company

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/10/26 5:00:07 PM ET
    $SSP
    Broadcasting
    Industrials

    SEC Form 4 filed by E.W. Scripps Company

    4 - E.W. SCRIPPS Co (0000832428) (Issuer)

    3/10/26 5:00:11 PM ET
    $SSP
    Broadcasting
    Industrials

    $AEY
    $ANTX
    $APLD
    $ARM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    SuperCom Secures 4th New Electronic Monitoring Contract in Kentucky, Expansion Momentum Continues

    Kentucky momentum continues as SuperCom advances its broader U.S. growth strategyDirect agency selection and incumbent displacement validate technology, execution, and market positioningNEW YORK, March 10, 2026 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today announced that it has secured a new direct agency electronic monitoring (EM) contract with a county government agency in Kentucky. The agreement marks SuperCom's 4th new contract in the state since mid-2024, building on the Company's growing momentum across neighboring jurisdictions. SuperCom will deploy it's PureSecurity GPS electronic monitoring

    3/10/26 9:24:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Canaan Inc. Provides February 2026 Bitcoin Production and Mining Operation Updates

    Doubles down on energy strategy with West Texas joint ventureSINGAPORE, March 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending February 28, 2026. Management Commentary"Our continued strategic execution highlights the importance of integrating energy resources into our strategy as we strengthen our focus on expanding our US footprint and continuing our long-standing track record of operational excellence," said Nangeng Zhang, chairman and chief executive officer of Canaan. "In February, we produced 86 BTC, bringing our total cryptocurrency holdings to a record-h

    3/10/26 9:05:00 AM ET
    $CAN
    $CIFR
    Semiconductors
    Technology
    Finance: Consumer Services
    Finance

    $AEY
    $ANTX
    $APLD
    $ARM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Monday.com downgraded by Jefferies with a new price target

    Jefferies downgraded Monday.com from Buy to Hold and set a new price target of $80.00

    2/23/26 8:32:39 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    $AEY
    $ANTX
    $APLD
    $ARM
    SEC Filings

    View All

    Applied Digital Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits

    8-K - Applied Digital Corp. (0001144879) (Filer)

    3/10/26 4:15:40 PM ET
    $APLD
    Finance: Consumer Services
    Finance

    AN2 Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Regulation FD Disclosure

    8-K - AN2 Therapeutics, Inc. (0001880438) (Filer)

    3/9/26 9:43:15 PM ET
    $ANTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14A filed by E.W. Scripps Company

    PRE 14A - E.W. SCRIPPS Co (0000832428) (Filer)

    3/9/26 4:09:34 PM ET
    $SSP
    Broadcasting
    Industrials

    $AEY
    $ANTX
    $APLD
    $ARM
    Leadership Updates

    Live Leadership Updates

    View All

    Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

    Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at Harvard Medical School and Brigham and Women's Hospital, Dr. Mina strengthens Invivyd's medical leadership Dr. Mina's research at Harvard focused on antibodies, vaccines, and infectious diseases with special expertise in COVID-19, measles, and other diseases, and will be a significant asset to Invivyd and the advancement of its pipelineWith more than 100 scientific publications and 10,000 citations, as well as hundreds of popular press interviews and op-eds, Dr. Mina is an expert in conducting research and conveying its meaning and impact to healthc

    3/5/26 7:01:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

    Continued clinical execution across TRACTr programs JANX007 and JANX008 JANX007 enrolling in Phase 1b Taxane-naïve patient population in metastatic castration-resistant prostate cancer (mCRPC) JANX008 enrolling expansion cohorts in defined tumor settings Initiated Phase 1 study of JANX011 in healthy volunteers Entered collaboration and exclusive worldwide license agreement with Bristol Myers Squibb to develop a novel tumor-activated therapeutic for solid tumors Appointment of William Go, M.D., Ph.D., as Chief Medical Officer Strong year-end cash position supporting continued pipeline execution Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharma

    2/26/26 4:01:00 PM ET
    $JANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    $AEY
    $ANTX
    $APLD
    $ARM
    Financials

    Live finance-specific insights

    View All

    Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

    Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.7 million after raising over $200 million from financing transactions in 2H 2025Announced initiation of DECLARATION Phase 3 pivotal clinical trial of vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data expected mid-2026; Fast Track designation for VYD2311 granted by FDA in December 2025DECLARATION trial on track with full enrollment achievedDECLARATION trial Independent Data Monitoring Committee (IDMC) prespecified review of unblinded VYD2311 safety data resulted in IDMC re

    3/5/26 7:03:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Babcock & Wilcox Reports Fourth Quarter and Full Year 2025 Results

    Revenue, Operating Income and EBITDA all ahead of street expectations Revenue in fourth quarter of $161.0 million Operating income in the fourth quarter of $12.2 million, compared to operating income of $2.6 million in the same period of 2024 Adjusted EBITDA from Continuing Operations in the fourth quarter of $16.4 million, a 53% increase compared to the same period of 2024 Parts & services revenues increased 17% in 2025, continuing to outperform expectations due to increased coal generation usage and higher baseload demand in North America Paid off outstanding bonds due February 2026 in December 2025 Signed full notice to proceed for a $2.4 billion AI data center project

    3/4/26 6:30:00 AM ET
    $APLD
    $BW
    Finance: Consumer Services
    Finance
    Building Products
    Industrials

    Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026

    NEW HAVEN, Conn., March 02, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, March 5, 2026, at 8:30 a.m. ET to discuss its fourth quarter and full-year 2025 financial results and provide a corporate update. Interested parties may join the live webcast by visiting this link. Analysts wishing to participate in the question-and-answer session should use this link. Those who plan on participating are advised to join 15 minutes prior to the start time. A recording of the webcast will be available on the company's investor rel

    3/2/26 4:10:00 PM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEY
    $ANTX
    $APLD
    $ARM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Invivyd Inc.

    SC 13D/A - Invivyd, Inc. (0001832038) (Subject)

    12/12/24 4:39:09 PM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Applied Digital Corporation

    SC 13D/A - Applied Digital Corp. (0001144879) (Subject)

    11/29/24 4:20:07 PM ET
    $APLD
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by JE Cleantech Holdings Limited

    SC 13D/A - JE Cleantech Holdings Ltd (0001905511) (Subject)

    11/25/24 6:13:31 AM ET
    $JCSE
    Miscellaneous manufacturing industries
    Consumer Discretionary